| abstract |
A sublingual pharmaceutical composition comprising 0.125-10% by weight of a central benzodiazepine receptor agonist selected from the group consisting of midazolam maleate, diazepam, lorazepam, bromazepam, triazolam, alprazolam, flunitrazepam and nitrazepam, and containing at least 70% by weight of the final formulation the following ternary mixture: i) 40-45% lactose ii) 15-27% sorbitol and iii) 12-16% cellulose. |